Found 783 matching trials
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease PHASE1 Background:
X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Show More Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Show More Learn More & Join Trial
PRO#0118: Decitabine Plus Mini Flu-Bu PHASE1 This is a single institution study of combining decitabine with fludarabine...
Show More Location
Hackensack University Medical Center - John Theurer Cancer Center
Learn More & Join Trial
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia PHASE2 The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Show More Location
University of Michigan Cancer Center
Learn More & Join Trial
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
Randomized Clinical Study Assessing Haplo vs. URD in AML NA This study compares haplo-identical family donor stem cell transplantation ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
UCSF Cancer Center and Cancer Research Institute
Learn More & Join Trial
Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma PHASE1 This phase I trial tests the effect of allogeneic Orca-Q stem cell transpla...
Show More Location
University of California Davis Comprehensive Cancer Center
Learn More & Join Trial
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial PHASE4 This study aims to determine whether the recurrence rate of high-risk acute...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial